Instruction for use: IsicomI want this, give me price
Dosage form: tablets
Active substance: Levodopa + Carbidopa*
N04BA02 Levodopa and a decarboxylase inhibitor
Dopaminomimetics in combination
Antiparkinsonics in combination
The nosological classification (ICD-10)
G20 Parkinson's disease: A trembling paralysis; Idiopathic Parkinsonism; Parkinson's disease; Symptomatic Parkinsonism
G21 Secondary Parkinsonism: Medicinal Parkinsonism; Parkinsonism; Parkinsonism symptomatic; Disorders of extrapyramidal system; Parkinson's Syndrome
Composition and release form
1 tablet contains levodopa 0.25 g and carbidopa 0.025 g.
Mode of action - antiparkinsonian, dopaminomimetic.
The antiparkinsonian effect is due to the conversion of levodopa to the central nervous system under the influence of dopa-decarboxylase in dopamine. To reduce the side effects caused by the formation of excess dopamine in the peripheral tissues, the drug includes carbidopa, an inhibitor of peripheral dopa-decarboxylase.
Indications of the drug Isicom
Parkinson's disease, Parkinsonism (except for caused by neuroleptics).
Hypersensitivity, expressed violations of the liver, kidneys, cardiovascular and endocrine systems, psychoses, zakratougolnaya glaucoma, melanoma, pregnancy, lactation, children's age.
Anorexia, nausea, vomiting, epigastric pain, ulcerogenic effect, orthostatic hypotension, arrhythmias, spontaneous movements, sleep disturbance, agitation, dizziness, depression (rarely), leukopenia, thrombocytopenia.
Dosing and Administration
Inside. Doses are selected strictly individually, the initial dose is 0.15-0.25 g of levodopa and 0.015-0.025 g of carbidopa (1 / 2-1 table). The maximum daily dose for levodopa is 1-4 g.
Storage conditions of the drug Isicom
In the dark place.
Keep out of the reach of children.
Shelf life of the drug Isicom
Do not use after the expiry date printed on the package.